Abvc Biopharma, Inc. financial data

Symbol
ABVC on Nasdaq
Location
44370 Old Warm Springs Blvd., Fremont, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - Apr 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30.5 % -11.4%
Debt-to-equity 116 % -54.1%
Return On Equity -268 % -8.5%
Return On Assets -84.5 % +23.2%
Operating Margin -923 % +79.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.8M shares +49.4%
Common Stock, Shares, Outstanding 15.4M shares +43.7%
Entity Public Float 7.2M USD +38.5%
Common Stock, Value, Issued 15.4K USD +43.7%
Weighted Average Number of Shares Outstanding, Basic 15M shares +53.7%
Weighted Average Number of Shares Outstanding, Diluted 15M shares +53.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 510K USD +234%
Cost of Revenue 763 USD -99.7%
Research and Development Expense 139K USD -82.6%
Operating Income (Loss) -2.56M USD +66.7%
Nonoperating Income (Expense) -826K USD +39.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.39M USD +62.6%
Income Tax Expense (Benefit) 355 USD
Net Income (Loss) Attributable to Parent -842K USD +70.3%
Earnings Per Share, Basic 0 USD/shares +87.7%
Earnings Per Share, Diluted 0 USD/shares +87.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 152K USD +399%
Accounts Receivable, after Allowance for Credit Loss, Current 1.53K USD -0.07%
Inventory, Net 11.5K USD
Assets, Current 1.47M USD -18.1%
Deferred Income Tax Assets, Net 34.3K USD -96.6%
Property, Plant and Equipment, Net 8.17M USD +2.76%
Operating Lease, Right-of-Use Asset 533K USD -24.7%
Other Assets, Noncurrent 127K USD
Assets 14.9M USD +86.5%
Employee-related Liabilities, Current 140K USD -86.8%
Accrued Liabilities, Current 3.7M USD +27%
Contract with Customer, Liability, Current 81.1K USD +2.03%
Liabilities, Current 6.73M USD +8.95%
Contract with Customer, Liability, Noncurrent 296K USD
Operating Lease, Liability, Noncurrent 167K USD -47.5%
Liabilities 6.92M USD +6.17%
Accumulated Other Comprehensive Income (Loss), Net of Tax 444K USD +90.4%
Retained Earnings (Accumulated Deficit) -69.8M USD -0.63%
Stockholders' Equity Attributable to Parent 5.4M USD +218%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.96M USD +446%
Liabilities and Equity 14.9M USD +86.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -540K USD +43.5%
Net Cash Provided by (Used in) Financing Activities 429K USD -53.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 15.4M shares +43.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -104K USD -80.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 760K USD +15.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.23K USD -8.24%
Deferred Tax Assets, Valuation Allowance 6.58M USD +5.3%
Deferred Tax Assets, Gross 6.58M USD +5.3%
Operating Lease, Liability 533K USD -24.7%
Depreciation 37.8K USD +61.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.93M USD +66.9%
Lessee, Operating Lease, Liability, to be Paid 547K USD -23%
Property, Plant and Equipment, Gross 11.5M USD +2.15%
Operating Lease, Liability, Current 366K USD -6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.7K USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year One 105K USD -70.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.01 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.6K USD +400%
Lessee, Operating Lease, Liability, to be Paid, Year Three 46.7K USD
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 46.7K USD
Operating Lease, Payments 117K USD +18.9%
Additional Paid in Capital 83.6M USD -2.81%
Depreciation, Depletion and Amortization 27.4K USD +15.4%
Share-based Payment Arrangement, Expense 1.13M USD -51.9%
Interest Expense 1.44M USD +333%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%